Active ingredientRifapentineCat. No. P-R055-001CAS 61379-65-5Family · Pharmaceutical analytical standards
Rifapentine
A rifamycin antibiotic, similar to rifampicin but carrying a cyclopentane ring, first synthesised in 1965 and approved in the United States in 1998; it is used against tuberculosis, including latent tuberculosis together with isoniazid. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The rifamycins owe their name to the 1955 French film 'Rififi': they were isolated in Milan in 1957 from a bacterium found in a soil sample collected near Saint-Raphaël, on the French Riviera.
Go to the active ingredient →Active ingredientRifapentineCat. No. P-R055-001CAS 61379-65-5
Isotopically labelled25-Desacetyl Rifapentine-d8Cat. No. P-R055-002
Isotopically labelledRifapentine-d9Cat. No. P-R055-003
Impurity25-Desacetyl RifapentineCat. No. P-R055-004CAS 79039-56-8
Impurity3-Formyl Rifapentine QuinoneCat. No. P-R055-005
Impurity3-Formyl-Desacetyl RifapentineCat. No. P-R055-006CAS 16783-97-4
ImpurityRifapentine Impurity 1Cat. No. P-R055-007CAS 27557-15-9
ImpurityRifapentine N-OxideCat. No. P-R055-009
ImpurityRifapentine QuinoneCat. No. P-R055-010No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.